PL4271359T3 - Kompozycja proszku ulegającego rozpadowi w jamie ustnej - Google Patents

Kompozycja proszku ulegającego rozpadowi w jamie ustnej

Info

Publication number
PL4271359T3
PL4271359T3 PL21839271.0T PL21839271T PL4271359T3 PL 4271359 T3 PL4271359 T3 PL 4271359T3 PL 21839271 T PL21839271 T PL 21839271T PL 4271359 T3 PL4271359 T3 PL 4271359T3
Authority
PL
Poland
Prior art keywords
powder composition
dispersible powder
orally dispersible
orally
composition
Prior art date
Application number
PL21839271.0T
Other languages
English (en)
Inventor
Francesc AGELL PUIG
Original Assignee
BioPharma Synergies, S. L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioPharma Synergies, S. L. filed Critical BioPharma Synergies, S. L.
Publication of PL4271359T3 publication Critical patent/PL4271359T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL21839271.0T 2020-12-30 2021-12-21 Kompozycja proszku ulegającego rozpadowi w jamie ustnej PL4271359T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20383177.1A EP4023210A1 (en) 2020-12-30 2020-12-30 Orodispersible powder composition
PCT/IB2021/062096 WO2022144691A1 (en) 2020-12-30 2021-12-21 Orodispersible powder composition

Publications (1)

Publication Number Publication Date
PL4271359T3 true PL4271359T3 (pl) 2026-05-11

Family

ID=74205598

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21839271.0T PL4271359T3 (pl) 2020-12-30 2021-12-21 Kompozycja proszku ulegającego rozpadowi w jamie ustnej

Country Status (7)

Country Link
US (1) US12582601B2 (pl)
EP (2) EP4023210A1 (pl)
JP (1) JP2024501157A (pl)
CN (1) CN116635013A (pl)
ES (1) ES3064347T3 (pl)
PL (1) PL4271359T3 (pl)
WO (1) WO2022144691A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024227385A1 (en) * 2024-03-28 2025-10-16 Athena Pharmaceutiques Sas Lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof
EP4702971A1 (en) * 2024-09-03 2026-03-04 Athena Pharmaceutiques SAS Method for preparation of lisdexamfetamine dimesylate dispersible tablet

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002019A1 (de) 1977-11-14 1979-05-30 Ciba-Geigy Ag Verfahren zur Herstellung von Organozinnverbindungen
US20060024335A1 (en) * 2004-07-29 2006-02-02 Roger Stier E Oral compositions which mask the bitter taste of a bitter-tasting agent
US20060198885A1 (en) 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
WO2007078726A2 (en) * 2005-12-16 2007-07-12 Merck & Co., Inc. Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
EP2538923A2 (en) * 2010-02-22 2013-01-02 Lupin Limited Taste-masked powder for suspension compositions of methylprednisolone
EP2948170B1 (en) * 2013-01-23 2020-08-19 Alvine Pharmaceuticals, Inc. Pharmaceutical compositions for treating celiac disease and gluten intolerance
CN111632023A (zh) * 2014-03-27 2020-09-08 Ucb法奇姆股份有限公司 包含左西替利嗪的药物组合物
WO2015200842A1 (en) * 2014-06-26 2015-12-30 MicroBiome Therapeutics LLC Composition comprising metformin and a microbiome modulator

Also Published As

Publication number Publication date
WO2022144691A1 (en) 2022-07-07
JP2024501157A (ja) 2024-01-11
EP4271359C0 (en) 2025-12-31
EP4271359B1 (en) 2025-12-31
CN116635013A (zh) 2023-08-22
ES3064347T3 (en) 2026-04-24
EP4023210A1 (en) 2022-07-06
US12582601B2 (en) 2026-03-24
EP4271359A1 (en) 2023-11-08
US20240366502A1 (en) 2024-11-07

Similar Documents

Publication Publication Date Title
EP4227390A4 (en) COMPOSITION CONTAINING A REFRIGERANT FLUID
EP4148096A4 (en) COMPOSITION
EP4094582A4 (en) COMPOSITION
DK3924443T3 (da) Compositions
EP4115893A4 (en) Anti-tumor composition
EP3565532A4 (en) ORAL DISPERSIBLE FILM COMPOSITION
EP4279545A4 (en) COMPOSITION
EP3756471A4 (en) ORAL INGESTION COMPOSITION
DK3706724T3 (da) Orale rifamycin-sv-sammensætninger
EP4404919A4 (en) DRIED NANOPARTICLE COMPOSITIONS
EP4103854A4 (en) A multipurpose screw
EP4281046C0 (en) NALTREXONE-BASED COMPOSITIONS
IL283375A (en) An orally active prodrug of gemcitabine
EP4284362A4 (en) Formulations
EP4256012C0 (en) COMPOSITION
EP4219052A4 (en) CYLINDRICAL CUTTER TWO SIZES
EP4291042C0 (en) COMPOSITION DERIVED FROM OATS
EP3846831C0 (en) COMPOSITIONS OF ASSOCIATIONS OF PROBIOTICS
EP4504168A4 (en) COMPOSITIONS CONTAINING CANNABINOIDS
JP1764353S (ja) レンチ
IL310652A (en) Formulations of radiprodil
EP4337751C0 (en) COMPOSITION
EP4223850A4 (en) COMPOSITION
EP4217455C0 (en) COMPOSITION
EP4188088A4 (en) Formulations